scispace - formally typeset
C

Cheryl Gillett

Researcher at King's College London

Publications -  146
Citations -  12223

Cheryl Gillett is an academic researcher from King's College London. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 52, co-authored 136 publications receiving 11077 citations. Previous affiliations of Cheryl Gillett include Guy's and St Thomas' NHS Foundation Trust & Guy's Hospital.

Papers
More filters
Journal ArticleDOI

Cyclin-dependent kinase inhibitor p27Kipl expression and interaction with other cell cycle-associated proteins in mammary carcinoma

TL;DR: It is shown that in clinical material p27 expression is associated with proliferative activity and while univariate analysis shows it to be a significant indicator of prognosis, this significance is lost in multivariate analysis when traditional prognostic factors are included in the model.
Journal ArticleDOI

Targeting the HOX/PBX dimer in breast cancer.

TL;DR: It is shown that HxR9 causes apoptosis in a number of breast cancer-derived cell lines and that sensitivity to HXR9 is directly related to the averaged expression of HOX genes HOXB1 through to HOXb9, providing a potential biomarker to predict the sensitivity of breast tumors to H XR9 or its derivatives.
Journal ArticleDOI

S100 protein in human mammary tissue—immunoreactivity in breast carcinoma, including Paget's disease of the nipple, and value as a marker of myoepithelial cells

TL;DR: S100 immunoreactivity is not a reliable means of differentiating between luminal epithelial and myoepithelial cells, and the possibility that staining with antibody to S100 protein may be affected by methods of fixation and immunohistochemical technique is discussed.
Journal ArticleDOI

Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies.

TL;DR: HMLVs are integral members of the MMTV family; MMTVs/H MLVs are genetically distinct from HERVs; and MMTV/HMLV DNA is not present in human breast cancer cell lines or clinical biopsies in the authors' locality.
Journal ArticleDOI

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

TL;DR: S-phase fraction was shown to be a significant prognostic marker in terms of overall survival (OS), relapse-free survival (RFS) and survival after relapse (SAR), and had independent prognostic significance when considering a range of other clinicopathological variables, namely tumour grade and stage, nodal status, patient age, tumour size, menstrual status and treatment details.